Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
- 2025-02
-
br Experimental Procedures br Author
2018-10-20
Experimental Procedures Author Contributions Acknowledgments Introduction Since their discovery and isolation in 1998, human embryonic stem cytokine inhibitors (hESCs) have been considered a potentially valuable tool for generating replacement cells for therapeutic purposes (Lanza et al
-
br Specification of germ cells in humans
2018-10-20
Specification of germ cells in humans The earliest identification of PGCs in the yolk sac was made by Fuss using transmission electron microscopy (TEM) during week 3 of life (Fig. 1). This work revealed that human PGCs are large spherical cells located amongst the smaller cells of the yolk sac en
-
br Experimental Procedures br Author Contributions br Acknow
2018-10-20
Experimental Procedures Author Contributions Acknowledgments Introduction MicroRNAs (miRNAs) are short, endogenous, non-coding RNAs that repress gene expression post-transcriptionally by destabilizing and/or repressing translation of target mRNAs. In the canonical biogenesis pathway, pri
-
br Experimental Procedures br Author Contributions br Acknow
2018-10-20
Experimental Procedures Author Contributions Acknowledgments B.Z. was supported by an NYSTEM post-doctoral training fellowship, The SKI Stem Cell Research Facility is supported by NYSTEM grants C029153 and C024175 and The Starr Foundation. The work was further supported in part by NIH/NCI g
-
br Results br Discussion We report the development of
2018-10-20
Results Discussion We report the development of a method to generate and proliferate iCx26GJCs from mouse iPSCs for use as a disease model and in inner-ear cell therapies targeting GJB2-related hearing loss, the most frequent type of hereditary deafness worldwide. Our induction method until da
-
Hello world!
2018-07-29
15636 records 1043/1043 page Previous First page 上5页 104110421043